Profile | GDS5420 / 221733_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 774.1 | 75 |
GSM1296119 | B_lesional_pre-dose | 800.94 | 76 |
GSM1296076 | C_lesional_pre-dose | 553.89 | 70 |
GSM1296092 | D_lesional_pre-dose | 681.37 | 73 |
GSM1296103 | E_lesional_pre-dose | 1387.34 | 84 |
GSM1296078 | F_lesional_pre-dose | 449.74 | 67 |
GSM1296107 | G_lesional_pre-dose | 572.13 | 70 |
GSM1296109 | H_lesional_pre-dose | 1158.99 | 82 |
GSM1296080 | I_lesional_pre-dose | 403.25 | 64 |
GSM1296090 | J_lesional_pre-dose | 566.02 | 70 |
GSM1296074 | K_lesional_pre-dose | 507.8 | 69 |
GSM1296111 | L_lesional_pre-dose | 800.6 | 76 |
GSM1296099 | M_lesional_pre-dose | 1120.32 | 81 |
GSM1296086 | O_lesional_pre-dose | 928.76 | 78 |
GSM1296117 | P_lesional_pre-dose | 743.03 | 75 |
GSM1296113 | Q_lesional_pre-dose | 561 | 70 |
GSM1296096 | R_lesional_pre-dose | 1236.28 | 82 |
GSM1296105 | S_lesional_pre-dose | 727.29 | 74 |
GSM1296098 | T_lesional_pre-dose | 496.64 | 67 |
GSM1296101 | U_lesional_pre-dose | 1026.36 | 80 |
GSM1296121 | V_lesional_pre-dose | 755.35 | 75 |
GSM1296088 | W_lesional_pre-dose | 643.4 | 72 |
GSM1296082 | X_lesional_pre-dose | 744.38 | 75 |
GSM1296115 | Y_lesional_pre-dose | 843.69 | 76 |
GSM1296084 | Z_lesional_pre-dose | 516.09 | 68 |
GSM1296072 | B_lesional_day8 | 517.01 | 68 |
GSM1296069 | L_lesional_day8 | 636.72 | 72 |
GSM1296071 | P_lesional_day8 | 467.08 | 66 |
GSM1296070 | Y_lesional_day8 | 568.82 | 70 |
GSM1296073 | V_lesional_day8 | 825.68 | 76 |
GSM1296034 | A_lesional_day15 | 328.57 | 59 |
GSM1296041 | G_lesional_day15 | 566.29 | 70 |
GSM1296035 | R_lesional_day15 | 942.64 | 78 |
GSM1296038 | U_lesional_day15 | 751.79 | 74 |
GSM1296047 | B_lesional_day15 | 563.53 | 70 |
GSM1296039 | E_lesional_day15 | 790.74 | 76 |
GSM1296042 | H_lesional_day15 | 461.58 | 66 |
GSM1296043 | L_lesional_day15 | 488.62 | 67 |
GSM1296037 | M_lesional_day15 | 563.51 | 69 |
GSM1296046 | P_lesional_day15 | 440.62 | 65 |
GSM1296044 | Q_lesional_day15 | 576.29 | 70 |
GSM1296045 | Y_lesional_day15 | 486.42 | 67 |
GSM1296025 | C_lesional_day15 | 174.27 | 51 |
GSM1296033 | D_lesional_day15 | 353.75 | 62 |
GSM1296027 | I_lesional_day15 | 170.76 | 51 |
GSM1296032 | J_lesional_day15 | 269.36 | 57 |
GSM1296024 | K_lesional_day15 | 204.37 | 53 |
GSM1296031 | W_lesional_day15 | 463.79 | 66 |
GSM1296028 | X_lesional_day15 | 300.65 | 59 |
GSM1296029 | Z_lesional_day15 | 325.28 | 60 |
GSM1296026 | F_lesional_day15 | 238.32 | 56 |
GSM1296030 | O_lesional_day15 | 391.38 | 64 |
GSM1296040 | S_lesional_day15 | 999.64 | 79 |
GSM1296036 | T_lesional_day15 | 607.92 | 70 |
GSM1296048 | V_lesional_day15 | 709.14 | 74 |
GSM1296059 | A_lesional_day43 | 1397.62 | 84 |
GSM1296066 | G_lesional_day43 | 462.83 | 66 |
GSM1296060 | R_lesional_day43 | 837.7 | 76 |
GSM1296063 | U_lesional_day43 | 841.09 | 76 |
GSM1296064 | E_lesional_day43 | 1097.15 | 80 |
GSM1296067 | H_lesional_day43 | 407 | 63 |
GSM1296062 | M_lesional_day43 | 964.6 | 78 |
GSM1296068 | Q_lesional_day43 | 449.43 | 65 |
GSM1296050 | C_lesional_day43 | 298.2 | 59 |
GSM1296057 | D_lesional_day43 | 735.49 | 74 |
GSM1296052 | I_lesional_day43 | 179.82 | 52 |
GSM1296054 | J_lesional_day43 | 332.65 | 60 |
GSM1296049 | K_lesional_day43 | 196.59 | 52 |
GSM1296055 | W_lesional_day43 | 613.18 | 71 |
GSM1296053 | X_lesional_day43 | 220.76 | 54 |
GSM1296058 | Z_lesional_day43 | 669.99 | 72 |
GSM1296051 | F_lesional_day43 | 412.62 | 65 |
GSM1296056 | O_lesional_day43 | 1215.67 | 82 |
GSM1296065 | S_lesional_day43 | 705.15 | 73 |
GSM1296061 | T_lesional_day43 | 636.26 | 71 |
GSM1296095 | A_non-lesional_pre-dose | 498.43 | 68 |
GSM1296120 | B_non-lesional_pre-dose | 567.02 | 70 |
GSM1296077 | C_non-lesional_pre-dose | 272.45 | 58 |
GSM1296093 | D_non-lesional_pre-dose | 369.53 | 62 |
GSM1296104 | E_non-lesional_pre-dose | 577.75 | 70 |
GSM1296079 | F_non-lesional_pre-dose | 221.38 | 55 |
GSM1296108 | G_non-lesional_pre-dose | 464.72 | 66 |
GSM1296110 | H_non-lesional_pre-dose | 505.83 | 67 |
GSM1296081 | I_non-lesional_pre-dose | 258.84 | 57 |
GSM1296091 | J_non-lesional_pre-dose | 402.84 | 64 |
GSM1296075 | K_non-lesional_pre-dose | 312.64 | 61 |
GSM1296112 | L_non-lesional_pre-dose | 505.27 | 67 |
GSM1296100 | M_non-lesional_pre-dose | 640.23 | 71 |
GSM1296087 | O_non-lesional_pre-dose | 157.94 | 51 |
GSM1296118 | P_non-lesional_pre-dose | 481.27 | 66 |
GSM1296114 | Q_non-lesional_pre-dose | 432.67 | 65 |
GSM1296097 | R_non-lesional_pre-dose | 602.19 | 71 |
GSM1296106 | S_non-lesional_pre-dose | 598.33 | 70 |
GSM1296102 | U_non-lesional_pre-dose | 560.59 | 69 |
GSM1296122 | V_non-lesional_pre-dose | 487.09 | 67 |
GSM1296089 | W_non-lesional_pre-dose | 436.31 | 65 |
GSM1296083 | X_non-lesional_pre-dose | 432.36 | 65 |
GSM1296116 | Y_non-lesional_pre-dose | 468.86 | 66 |
GSM1296085 | Z_non-lesional_pre-dose | 245.59 | 56 |